From May 31 to June 4, 2025, the 35th Regional ISBT Congress (ISBT), an annual grand event in the global field of blood transfusion, was grandly held at the Allianz MiCo in Italy. 
The ISBT is one of the largest and most influential international academic gatherings in the global field of blood transfusion. Each year, it attracts thousands of blood transfusion medicine experts, scholars, medical staff, representatives from industry regulatory agencies, and relevant enterprises from around the world to jointly explore the latest scientific research progress, technological innovations, and policies and regulations in blood transfusion medicine. It serves as an important platform to showcase cutting-edge technologies and promote international cooperation. The theme of this year's ISBT is "Innovation, Integration, Connectivity".

As a leader in China's safe blood transfusion field, Shuangwei Biotechnology made a brilliant appearance with a variety of safe blood transfusion-related equipment and devices. It demonstrated innovative and diversified solutions for blood stations and hospitals to industry experts, partners, and potential customers from around the world, attracting experts, scholars, distribution partners, and industry peers to stop and visit.
Shuangwei Biotechnology participated in this exhibition with the aim of deeply connecting with the global market. It not only focuses on core safe blood transfusion products to expand its influence but also shares its latest breakthroughs in transfusion safety and efficiency improvement. At our booth, in addition to showcasing leukocyte filtration transfusion technology, the company also highlighted new products in plasma safety processing, autologous platelet-rich plasma preparation, and blood component separation.
During the exhibition, the Shuangwei Biotechnology team had extensive and in-depth exchanges with new and old distribution partners, representatives from medical institutions, and experts from blood stations and blood centers from Europe, Asia, Africa, and Latin America. Through one-on-one negotiations and product demonstrations, Shuangwei Biotechnology not only shared its product concepts but also gained a clear understanding of the differentiated needs and challenges in different regional markets worldwide.
Shuangwei Biotechnology is committed to building a safe blood transfusion base in China and becoming the most trusted manufacturer and service provider to boost global transfusion safety and efficiency. The successful appearance at the ISBT in Milan not only demonstrates the company's innovative strength and product quality, but also highlights Shuangwei Biotechnology's determination to actively integrate into the global industrial chain and contribute Chinese wisdom to the advancement of global blood transfusion medicine.

Shuangwei Biotechnology will continue to adhere to the business philosophy of integrity, pragmatism, innovation and transcendence, continue to increase R&D investment, deepen core technologies, and use safer, more efficient and smarter products and services to meet the continuously upgrading needs of global customers, and work together to safeguard human life and health. From June 20th to 24th, 2026, the 39th ISBT will be held in Kuala Lumpur, Malaysia. Shuangwei Biotechnology looks forward to meeting you again!